It's interesting, way back in 2016 when i first became...

It's interesting, way back in 2016 when i first became interested in orthocell and was doing my research on the company i always do a list of pros and cons. One on my pros list was great innovative products. One on my con list was little or no interest in their products, now i feel we are right at the cross roads. They now to me have developed their products to even broader applications and the interest in them is getting stronger. The key now is partnerships, this in my opinion is critical to company and commercial success. I feel the next 18 months will be crucial in how that all plays out.

One thing that concerns me is the timing of the end of the jnj trial and what happens there. Is a partnership possible on a product that doesn't have fda approval? I am a bit unsure how that is going to play out.